Nexteq PLC Transaction in Own Shares and Total Voting Rights

RNS Number : 5877M

Nexteq PLC

18 November 2024

 

18 November 2024

Nexteq plc

("Nexteq" or the "Group")

 

Transaction in Own Shares

and

Total Voting Rights

 

 

Nexteq PLC (the "Company") announces that on 15 November 2024 it purchased 39,000 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 73.00 pence each, to be held in treasury.

Further to the above transaction, the Company advises that its issued share capital stands at 66,539,060 Ordinary Shares, with 5,304,398 Ordinary Shares held in treasury. Consequently, the total voting rights of the Company is 61,234,662.

 

The above voting rights figure of 61,234,662 may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Nexteq PLC Duncan Faithfull, Chief Executive Officer Matt Staight, Chief Financial Officer	Telephone: [phone]
Nominated Adviser and Joint Broker: Cavendish Capital Markets Ltd Matt Goode / Edward Whiley (Corporate Finance) Tim Redfern / Harriet Ward (ECM)	Telephone: [phone]
Joint Broker: Canaccord Genuity Limited Simon Bridges / Andrew Potts	Telephone: [phone]
Financial PR: Alma Strategic Communications Hilary Buchanan / Kieran Breheny	Telephone: [phone]

 

Aggregate information:

Venue	Volume-weighted average price (pence per share)	Aggregate volume
AIMX	73.00	39,000

 

Individual transactions:

Number of shares purchased	Transaction price (pence per share)	Time of transaction	Trading venue
39,000	73.00	15:24:31	AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

POSEAKFPFSDLFEA